LUNG · Company research

Pulmonx Corporation (LUNG): Valuation Analysis

Available valuation snapshots and ratios; unavailable metrics remain blank.

RESEARCH CONTEXT

Understand the numbers

Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.

1records availableHealthcare

Valuation Analysis data

Database-backed records only

1 rows
valuation datepricemarket capenterprise valuepeforward pepegprice salesprice bookprice fcf
Oct 8, 20261.84$83,238,773.5227395773.52———3.65788247143610482.1236547994693336—

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.